#biologics
Contract Manufacturing Organizations (CMOs) Emerging Market Outsourcing Report 2026: China Releases New Revision of Drug Administration Law, Aiming to Spur Innovation
Emerging markets offer significant opportunities in pharmaceutical manufacturing, highlighted by trends in CMOs, M&A activities, and service agreements. Insights into biologics, chemical APIs, and dose manufacturing in clinical and commercial settings are cru…
Biologics CDMO Research Report 2026: $48.07 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
The biologics CDMO market presents growth opportunities driven by increasing demand for cell and gene therapies, advancements in bioprocessing technologies, and the expansion of global manufacturing capacities. The rise in biosimilar pipelines and need for co…